| Name | Title | Contact Details |
|---|
Rock & Brews Restaurants is a casual dining chain founded in 2012 by Paul Stanley and Gene Simmons of the band Kiss, along with restaurateur Michael Zislis and partners Dave and Dell Furano. Based in Manhattan Beach, California, the restaurant features a rock-and-roll theme that enhances the dining experience. The menu offers classic American comfort food made from locally sourced ingredients, alongside a selection of craft beers with up to 24 options on tap. Rock & Brews creates a family-friendly atmosphere with amenities like play areas for children and spaces for adults to socialize, all while showcasing rock music videos on LED screens. The brand has expanded to over 23 locations across seven states, including California, Florida, and Texas, and is also present in airports and casinos. Rock & Brews appeals to a diverse customer base, from families to rock music fans, by combining quality food, craft beer, and a lively environment that celebrates the spirit of rock music.
Founded in 1904, the Fédération Internationale de Football Association (FIFA) is the umbrella organisation of its members, currently 211 national football associations. Its main objectives, enshrined in its statutes, are to develop football around the world, to stage international competitions and to protect the integrity of football (against match manipulation, doping etc.). FIFA is composed of a number of political bodies (such as the FIFA Congress and the FIFA Council) and the administration. The highest political position is the FIFA President, elected every four years by FIFAs member associations. The FIFA administration, with more than 800 people from over 60 nations, is based in Zurich. It is run by the Secretary General (CEO). FIFA stages FIFA World Cups™ in various forms such as youth, mens and womens, futsal, beach soccer or club competitions. The mens FIFA World Cup™ is not only the most popular single sporting event in the world but also the financial backbone for FIFA and its efforts to develop football worldwide. The financial success of the FIFA World Cup™ allows FIFA to run a wide range of football development programmes and to provide funds, infrastructure and know-how to its member associations through the FIFA Forward Development Programme. For more information visit our website.
The Familie specializes in talent representation across sports and music.
High to Low Voltage has made a name for itself sourcing electrical solutions for projects of all sizes, from smaller companies to large-scale data centers with enormous energy demands. Our expert sales team knows how to find the perfect equipment regardless of your electrical needs. High to Low Voltage. A business born out of a love of electrical equipment and necessity! Weve been problem-solving urgent electrical equipment needs for over 20 years, eager to put that experience to work for you in the moments that you need it most.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.